FMR LLC - EVELO BIOSCIENCES INC ownership

EVELO BIOSCIENCES INC's ticker is EVLO and the CUSIP is 299734103. A total of 50 filers reported holding EVELO BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
FMR LLC ownership history of EVELO BIOSCIENCES INC
ValueSharesWeighting
Q1 2023$5,853,628
-77.9%
32,394,178
+97.2%
0.00%
-100.0%
Q4 2022$26,449,645
-21.9%
16,428,351
+1.4%
0.00%
-25.0%
Q3 2022$33,856,000
-0.9%
16,199,055
+0.1%
0.00%
+33.3%
Q2 2022$34,152,000
+25.2%
16,185,709
+101.2%
0.00%
+50.0%
Q1 2022$27,277,000
-44.0%
8,046,489
+0.3%
0.00%
-50.0%
Q4 2021$48,676,000
-13.7%
8,018,992
+0.1%
0.00%0.0%
Q3 2021$56,389,000
-48.7%
8,009,743
+0.0%
0.00%
-55.6%
Q2 2021$110,003,000
+28.5%
8,006,076
+0.1%
0.01%
+28.6%
Q1 2021$85,603,000
+4.1%
8,000,242
+17.6%
0.01%0.0%
Q4 2020$82,253,000
+212.1%
6,803,365
+36.0%
0.01%
+133.3%
Q3 2020$26,355,000
+18.2%
5,000,985
+9.9%
0.00%
+50.0%
Q2 2020$22,301,000
+84.4%
4,551,219
+41.3%
0.00%0.0%
Q1 2020$12,094,000
-8.1%
3,220,853
-0.7%
0.00%
+100.0%
Q4 2019$13,164,000
-34.8%
3,242,419
-2.0%
0.00%
-50.0%
Q3 2019$20,191,000
-33.2%
3,309,953
-1.7%
0.00%
-50.0%
Q2 2019$30,242,000
+13.7%
3,367,653
+1.3%
0.00%
+33.3%
Q1 2019$26,601,000
-38.2%
3,325,107
+0.6%
0.00%
-50.0%
Q4 2018$43,011,000
+11.4%
3,306,007
+1.3%
0.01%
+50.0%
Q3 2018$38,611,000
+4.8%
3,264,907
-1.4%
0.00%0.0%
Q2 2018$36,832,0003,311,1070.00%
Other shareholders
EVELO BIOSCIENCES INC shareholders Q4 2020
NameSharesValueWeighting ↓
HARBOURVEST PARTNERS LLC 3,063,505$37,038,00014.47%
Mayo Clinic 484,953$5,863,0007.05%
Flagship Pioneering Inc. 22,900,069$276,862,0005.04%
Trustees of Columbia University in the City of New York 113,850$1,376,0001.84%
Alphabet Inc. 1,060,495$12,821,0000.62%
Artal Group S.A. 700,000$8,463,0000.18%
Larson Financial Group LLC 28,353$343,0000.12%
PEDDOCK CAPITAL ADVISORS, LLC 3,663$44,0000.02%
CREDIT SUISSE AG/ 2,705,511$32,710,0000.02%
FMR LLC 6,803,365$82,253,0000.01%
View complete list of EVELO BIOSCIENCES INC shareholders